XClose

UCL Faculty of Life Sciences

Home
Menu

EMMBRAce Project

Helping you to deliver bispecific antibody therapy to patients in the UK.

With exciting NICE approvals of Teclistamab and Eranatamab, we want to ensure patients with Myeloma across the UK have fair access to these treatments. However, there are challenges to delivery. We are a group of NHS haematology healthcare professionals across the UK that are working to support hospitals to deliver this new therapy to patients.

This website contains resources to support the development of services to provide bispecific antibodies to patients with Multiple Myeloma. This project is ongoing and resources will be added as they are developed. We aim to develop and provide:

  • Guidance on service development
  • Templates for referrals
  • Educational resources

About us

This project is being led and overseen by a steering group involving a multidisciplinary team of NHS doctors, nurses and pharmacists from across the UK alongside charity and industry partners. 

Contact us

You can contact the team at: Uclh.emmbrace.queries@nhs.net

Image credits: Photos designed by Freepik

Mature couple speaking to healthcare worker

Mature patient being given medication